A Phase 3, Double-blind, Randomized Study of the Safety, Tolerability, and Analgesic Efficacy of Multiple Doses of Ketorolac Tromethamine Administered Intranasally for Postoperative Pain.
Phase of Trial: Phase III
Latest Information Update: 10 Feb 2017
At a glance
- Drugs Ketorolac (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Luitpold Pharmaceuticals
- 05 May 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 05 May 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
- 05 Nov 2010 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History